Prestige Wealth Management Group LLC Alnylam Pharmaceuticals, Inc. Transaction History
Prestige Wealth Management Group LLC
- $465 Million
- Q2 2025
A detailed history of Prestige Wealth Management Group LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 184 shares of ALNY stock, worth $88,516. This represents 0.01% of its overall portfolio holdings.
Number of Shares
184
Previous 316
41.77%
Holding current value
$88,516
Previous $85,000
29.41%
% of portfolio
0.01%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding ALNY
# of Institutions
759Shares Held
115MCall Options Held
584KPut Options Held
661K-
Capital World Investors Los Angeles, CA16.8MShares$8.08 Billion0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$6.4 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.59 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.19MShares$3.46 Billion0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.28MShares$2.06 Billion0.88% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $59.2B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...